drugset / Trial / NCT00268879
Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to investigate whether renzapride will help alleviate the symptoms associated with constipation predominant irritable bowel syndrome in female patients.
Timeline
- Start
- 2005-12
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Renzapride | Small molecule | 2 mg | Oral |
| Subject | Renzapride | Small molecule | 4 mg | Oral |